Keywords: ranbaxy, gets, go-ahead, generic, tylenol, version, usa
Ranbaxy gets go-ahead for generic Tylenol version in USA
Article | 06 December 2001
Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of RanbaxyLaboratories, has received US approval for acetaminophen and codeine phosphate tablets USP, 300mg/30mg ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
